Aardvark Therapeutics Inc. Common Stock (AARD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aardvark Therapeutics Inc...

    NASDAQ: AARD · Real-Time Price · USD
    17.05
    0.97 (6.03%)
    At close: Oct 06, 2025, 3:59 PM
    16.70
    -2.05%
    After-hours: Oct 06, 2025, 05:09 PM EDT

    Aardvark Therapeutics Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 -20.59M -7.21M -13.56M
    Depreciation & Amortization
    		 16K 97K 110K
    Stock-Based Compensation
    		 439K 313K 412K
    Other Working Capital
    		 775K -857K -1.34M
    Other Non-Cash Items
    		 473K 1.05M 3.81M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 1.57M -81K -1.31M
    Operating Cash Flow
    		 -18.09M -5.82M -10.54M
    Capital Expenditures
    		 -109K n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -11.89M n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a -1M
    Investing Cash Flow
    		 -12M n/a -1M
    Debt Repayment
    		 n/a n/a -1M
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 -3.34M n/a 1M
    Financial Cash Flow
    		 81.99M n/a 225K
    Net Cash Flow
    		 51.91M -5.82M -11.32M
    Free Cash Flow
    		 -18.2M -5.82M -10.54M

    Add to Watchlist